Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Trial for Fractomer™ Biomatrix: Safety Assessment in Healthy Human Participants

NCT07151638 is registered in ClinicalTrials.gov with inSoma Bio, Inc. as lead sponsor.

NCT NCT07151638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07151638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Trial for Fractomer™ Biomatrix: Safety Assessment in Healthy Human Participants
Lead sponsor
inSoma Bio, Inc.
Phase
Not applicable
Overall status
Suspended
Start date
August 11, 2025
Completion date
January 22, 2027
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue, soft tissue defects, subcutaneous injection